A review published in JAMA Network Open examined how social media influencers shape what people learn about and how they approach prescription medications, and found that influencer promotion is frequently paired with misleading information and gaps in regulatory oversight. Study author Raffael Heiss, PhD, notes influencers often give medication advice despite financial incentives or limited medical training, and that disclosure rules have not kept up with social media practices. The review highlights how personal narratives can mask promotional intent and make incomplete or inaccurate information feel authentic.
Pharmaceutical companies increasingly work with a range of influencers, including so-called patient influencers who share personal stories that can be persuasive. While those stories may offer support and reduce isolation for some people, the review cautions they can also spread misinformation, encourage improper use, or create dangerous drug interactions—risks that may be amplified when content comes from clinicians or appears clinical.
Kanwar Kelley, MD, who was not involved in the review, observed that influencer content can blur the line between anecdote and clinical guidance, reducing the skepticism viewers might apply to traditional prescription marketing. He stresses that personal anecdotes are not a substitute for clinical evidence and calls for clearer conflict-of-interest disclosures and explicit discussion of risks, benefits, and alternatives.
The authors analyzed 12 peer-reviewed studies addressing topics such as contraceptive advertising, performance-enhancing drugs, and broader pharmaceutical promotion. Common themes across the literature included ineffective regulatory oversight and inconsistent disclosure practices; misinformation driven by influencers’ limited expertise coupled with audience low health literacy; and parasocial storytelling that obscures the difference between personal testimony and paid promotion.
The evidence base is limited and fragmented, but the review’s authors and outside experts say it points to an urgent need for updated regulatory guidance, enforceable and standardized disclosure rules, targeted digital health literacy programs, and stronger platform accountability. Clinicians such as Nissa Keyashian, MD, advise people to check an influencer’s clinical credentials and any sponsorships or conflicts of interest, and to seek clear disclosure. Heiss recommends exercising caution when influencers emphasize benefits, downplay risks, or wrap recommendations in emotional stories, and he urges consulting a doctor or pharmacist before acting on online advice.
Improving patient–physician dialogue and refining digital advertising frameworks are seen as key steps to protect patient safety and maintain trust as social media continues to shape how people obtain health information.